NetraMark Holdings Inc.

CNSX:AIAI Stock Report

Market Cap: CA$38.1m

NetraMark Holdings Management

Management criteria checks 2/4

NetraMark Holdings' CEO is George Achilleos, appointed in Feb 2022, has a tenure of 2.75 years. total yearly compensation is CA$265.00K, comprised of 90.6% salary and 9.4% bonuses, including company stock and options. directly owns 1.68% of the company’s shares, worth CA$641.52K. The average tenure of the management team and the board of directors is 2.8 years and 2.4 years respectively.

Key information

George Achilleos

Chief executive officer

CA$265.0k

Total compensation

CEO salary percentage90.6%
CEO tenure2.8yrs
CEO ownership1.7%
Management average tenure2.8yrs
Board average tenure2.4yrs

Recent management updates

Recent updates

Nurosene Health (CSE:MEND) Is In A Good Position To Deliver On Growth Plans

Sep 08
Nurosene Health (CSE:MEND) Is In A Good Position To Deliver On Growth Plans

CEO Compensation Analysis

How has George Achilleos's remuneration changed compared to NetraMark Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-CA$11m

Mar 31 2024n/an/a

-CA$12m

Dec 31 2023n/an/a

-CA$13m

Sep 30 2023CA$265kCA$240k

-CA$14m

Jun 30 2023n/an/a

-CA$13m

Mar 31 2023n/an/a

-CA$12m

Dec 31 2022n/an/a

-CA$13m

Sep 30 2022CA$220kCA$220k

-CA$13m

Jun 30 2022n/an/a

-CA$9m

Mar 31 2022n/an/a

-CA$10m

Dec 31 2021n/an/a

-CA$8m

Sep 30 2021CA$32kCA$32k

-CA$5m

Compensation vs Market: George's total compensation ($USD189.54K) is about average for companies of similar size in the Canadian market ($USD170.32K).

Compensation vs Earnings: George's compensation has increased whilst the company is unprofitable.

CEO

George Achilleos

2.8yrs

Tenure

CA$265,000

Compensation

Mr. George Achilleos serves as Chief Executive Officer of NetraMark Holdings Inc. (formerly known as Nurosene Health Inc.) from February 17, 2022 and serves as its Director since March 28, 2024 and was its...

Leadership Team

NamePositionTenureCompensationOwnership
George Achilleos
CEO & Director2.8yrsCA$265.00k1.68%
CA$ 641.5k
Josh Spiegel
President2yrsCA$403.86k3.9%
CA$ 1.5m
Daniel Gallucci
Founder3.9yrsCA$32.00kno data
Joseph Geraci
Founder3.1yrsCA$200.00k6.14%
CA$ 2.3m
Swapan Kakumanu
Chief Financial Officer2.3yrsCA$78.00kno data
Jaime Hackett
Vice President of Marketing1.8yrsno datano data
Luca Pani
Chief Innovation & Regulatory Officer and Chief Medical Advisor3.4yrsno data1.42%
CA$ 541.1k
Kaveh Kavoosi
Head of Progressive Medicineno datano datano data
Larry Alphs
Chief Medical Officer & Member of Advisory Boardless than a yearno datano data
Mark Smithyes
President of NetraMark3yrsno datano data

2.8yrs

Average Tenure

54yo

Average Age

Experienced Management: AIAI's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
George Achilleos
CEO & Directorless than a yearCA$265.00k1.68%
CA$ 641.5k
Daniel Gallucci
Founder3.7yrsCA$32.00kno data
Joseph Geraci
Founder2.4yrsCA$200.00k6.14%
CA$ 2.3m
Larry Alphs
Chief Medical Officer & Member of Advisory Board1.7yrsno datano data
Chuck McBride
Member of Advisory Boardno datano datano data
Kevin Taylor
Independent Chairman of the Board3yrsno data0.34%
CA$ 130.5k
William Travis
Member of Advisory Boardno datano datano data
Andrew Parks
Independent Director3.7yrsno data0.78%
CA$ 297.0k
Peter Carlisle
Member of Advisory Boardno datano datano data
Amal Wolfe
Member of Advisory Boardno datano datano data
Dean Sebastian
Member of Advisory Boardno datano datano data
Dhananja Jayalath
Member of Advisory Board2.3yrsno datano data

2.4yrs

Average Tenure

Experienced Board: AIAI's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.